Molecular Partners AG (MOLN)
Nasdaq: MOLN · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2021
Who owns Molecular Partners AG
As filed with the SECHolders of 5% or more
2
Suvretta Capital Management, LLC holds 10.6% of Common Shares, CHF 0.10 nominal value per share, as its SCHEDULE 13G filed May 2, 2025 says.
Directors and officers
n/a
The record holds no Form 3, 4 or 5 for this company yet.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Suvretta Capital Management, LLC
SCHEDULE 13G · filed May 2, 2025 · Common Shares, CHF 0.10 nominal value per share
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
SCHEDULE 13G · filed Jul 17, 2025 · Common Shares
What MOLN reports owning in othersstakes of 5% or more, and other ties
Molecular Partners AG reports no stake in another company in the record.
Insider tradesForm 4
The record holds no insider filings for this company yet.